TY - JOUR
T1 - Therapeutic recommendations in HFE hemochromatosis for p.Cys282Tyr (C282Y/C282Y) homozygous genotype
AU - Contributors and Hemochromatosis International Taskforce
AU - Adams, Paul
AU - Altes, Albert
AU - Brissot, Pierre
AU - Butzeck, Barbara
AU - Cabantchik, Ioav
AU - Cançado, Rodolfo
AU - Distante, Sonia
AU - Evans, Patricia
AU - Evans, Robert
AU - Ganz, Tomas
AU - Girelli, Domenico
AU - Hultcrantz, Rolf
AU - McLaren, Gordon
AU - Marris, Ben
AU - Milman, Nils
AU - Nemeth, Elizabeta
AU - Nielsen, Peter
AU - Pineau, Brigitte
AU - Piperno, Alberto
AU - Porto, Graça
AU - Prince, Dianne
AU - Ryan, John
AU - Sanchez, Mayka
AU - Santos, Paulo
AU - Swinkels, Dorine
AU - Teixeira, Emerência
AU - Toska, Ketil
AU - Vanclooster, Annick
AU - White, Desley
N1 - Publisher Copyright:
© 2018, The Author(s).
PY - 2018/3/1
Y1 - 2018/3/1
N2 - Although guidelines are available for hereditary hemochromatosis, a high percentage of the recommendations within them are not shared between the different guidelines. Our main aim is to provide an objective, simple, brief, and practical set of recommendations about therapeutic aspects of HFE hemochromatosis for p.Cys282Tyr (C282Y/C282Y) homozygous genotype, based on the published scientific studies and guidelines, in a form that is reasonably comprehensible to patients and people without medical training. This final version was approved at the Hemochromatosis International meeting on 12th May 2017 in Los Angeles.
AB - Although guidelines are available for hereditary hemochromatosis, a high percentage of the recommendations within them are not shared between the different guidelines. Our main aim is to provide an objective, simple, brief, and practical set of recommendations about therapeutic aspects of HFE hemochromatosis for p.Cys282Tyr (C282Y/C282Y) homozygous genotype, based on the published scientific studies and guidelines, in a form that is reasonably comprehensible to patients and people without medical training. This final version was approved at the Hemochromatosis International meeting on 12th May 2017 in Los Angeles.
UR - http://www.scopus.com/inward/record.url?scp=85044480865&partnerID=8YFLogxK
U2 - 10.1007/s12072-018-9855-0
DO - 10.1007/s12072-018-9855-0
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.editorial???
C2 - 29589198
AN - SCOPUS:85044480865
SN - 1936-0533
VL - 12
SP - 83
EP - 86
JO - Hepatology International
JF - Hepatology International
IS - 2
ER -